Notice of Intent to Source Accelerating Care Transformation (ACT) Support HT0011-25-R-E009

This is a notice of intent to sole source a procurement under 10 U.S.C. 3204(a)(2) FAR 6.302-2 – Unusual and compelling urgency." The contractor shall provide Accelerating Care Transformation (ACT) support to include diagnostics, future state modeling, implementation, and solution management at all venture sites. This support includes change and configuration management for current and any future versions of the ACT. To continue the integration of this transformation, the contractor will provide research, planning and implementation into other clinical areas to further enable a patient-centered, digitally enabled care delivery system. Also, identify strategic focus areas and assess value creation potential. Assess and facilitate alignment on range of potential focus areas for DHA (e.g., care attraction, digital health, performance improvement, human capital). Determine value creation potential based on MHS and industry experience. Develop cohesive strategy to Inform POM planning and Investment needs. Based on sized focus areas, identify likely investment needs to enable value capture against the strategy to inform future planning and budgeting processes. Size the investment needs and provide private sector benchmarks based on expected return /value capture. Conduct sessions with DHA senior and key stakeholders to pursue outputs. Develop communications collateral strategy. The applicable NAICS Code is 541611 Administrative Management and General Management Consulting Services. The DHA began the Healthcare prototype Transformation (HPT) accelerator in support of DHA Strategy Plan in September 2023 and requires seamless continuity of services to continue its design and implementation. These time-sensitive requirements must be completed by a vendor that possesses a deep understanding of the DHA and MHS organizations, operations, management, and policies from a clinic, MTFs, regional and Defense Health Head Quarter perspective and can rapidly continue the work that has been ongoing since September 2023 immediately and without a need for ramp-up. DHA intends to award this requirement to Transformcare, LLC., under the authority 10 U.S.C. 3204(a)(2). This notice of intent is NOT a request for competitive quotes; however, all responsible sources may submit a capability statement or quotation which shall be considered by the agency. Capability statements or quotes, if received timely, will be considered; however, a determination by the Government not to compete the requirement based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Responses shall be emailed to Kevin Hodge, kevin.d.hodge8.civ@health.mil and author.e.sandlain.ctr@health.mil no later than 19 September 2025, 12:30 p.m. Central Time, and shall include the control number HT0011-25-R-E009 in the subject line. Late responses will not be considered.